Showing 1211-1220 of 23044 results for "".
Paraclinical Optic Nerve Tests in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/paraclinical-optic-nerve-tests-in-multiple-sclerosis/54605/Confirming optic neuritis—and, by extension, optic nerve involvement as a distinct anatomic region within the McDonald criteria—requires careful integration of the individual’s history, a thorough neuro-ophthalmic examination, and judicious interpretation of diagnostic tests.Updates in Major Depressive Disorder with Insomnia
https://reachmd.com/programs/cme/updates-in-major-depressive-disorder-with-insomnia/36556/Join us to learn about the emerging data in the management of major depressive disorder with insomnia.Beyond Steroidal MRAs: The Nonsteroidal MRA Lens in HF
https://reachmd.com/programs/cme/beyond-steroidal-mras-the-nonsteroidal-mra-lens-in-hf/49198/Examine how nonsteroidal MRAs inform risk-based treatment in HFpEF and HFmrEF, including stable patients with ongoing cardio-kidney-metabolic risk.Targeting CCR4 in CAR-Associated Peripheral T-Cell Lymphoma
https://reachmd.com/programs/project-oncology/targeting-ccr4-in-car-associated-peripheral-t-cell-lymphoma/37205/FDA Approves Remdesivir, the First COVID-19 Treatment
https://reachmd.com/programs/the-drug-report/fda-approves-remdesivir-the-first-covid-19-treatment/11970/Learn about Remdesivir, the first FDA-approved treatment for the SARS-CoV-2 virus.Highlights from ENDO, the 95th Annual Meeting of The Endocrine Society
https://reachmd.com/programs/conference-coverage/highlights-from-endo-the-95th-annual-meeting-of-the-endocrine-society/6824/Highlights from ENDO, the 95th Annual Meeting of The Endocrine Society. The Endocrine Society is the world's oldest, largest, and most active organization devoted to research on hormones and the clinical practice of endocrinology. Download the program to hear global thought leaders discuss the neweRecognizing Multiple Sclerosis Awareness Month: Ways to Make an Impact
https://reachmd.com/programs/neurofrontiers/recognizing-multiple-sclerosis-awareness-month-ways-to-make-an-impact/32369/March is Multiple Sclerosis Awareness Month. Learn about how you can support patients and raise awareness through education, advocacy, and community engagement.Reducing the Burden of HPV-associated Cancer & Disease, Part 3
https://reachmd.com/programs/grand-rounds-nation/reducing-the-burden-of-hpv-associated-cancer-disease-part-3/6711/This session of Grand Rounds explores the burden of human papillomavirus (HPV) -associated cancer and disease in the United States and prevention through HPV vaccination. Each year, there are an estimated 26,000 HPV-attributable cancers in the United States. About 17,000 occur in women, most of whicImproving Home BP Monitoring: Inside the AMA’s Validated Device Listing
https://reachmd.com/programs/perspectives-ama/ama-validated-devices-for-home-bp-monitoring/33011/Accurate home blood pressure monitoring is vital for effective hypertension care, and the AMA’s Validated Device Listing (VDL) helps clinicians and patients confidently select devices that meet rigorous international accuracy standards. Learn more about how the VDL ensures device reliability and thePartnering for Better Hypertension Outcomes: How AMA and Azara Support Providers
https://reachmd.com/programs/perspectives-ama/precision-measurements-patient-collaborations-hypertension-management/33010/By embedding evidence-based metrics directly into existing workflows, the partnership between the American Medical Association (AMA) and Azara Healthcare supports providers in proactively managing hypertension. To learn more about how integrating the AMA MAP™ Hypertension Quality Improvement Program